{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T18:52:25Z","timestamp":1774291945113,"version":"3.50.1"},"reference-count":78,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T00:00:00Z","timestamp":1585785600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI128737"],"award-info":[{"award-number":["AI128737"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0230711","type":"journal-article","created":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T17:30:00Z","timestamp":1585848600000},"page":"e0230711","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":8,"title":["Replication-inducible vaccinia virus vectors with enhanced safety in vivo"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7295-7547","authenticated-orcid":true,"given":"Caitlin M.","family":"O\u2019Connell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9141-3246","authenticated-orcid":true,"given":"Brittany","family":"Jasperse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caitlin J.","family":"Hagen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison","family":"Titong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulo H.","family":"Verardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2020,4,2]]},"reference":[{"issue":"4","key":"pone.0230711.ref001","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1093\/infdis\/142.4.636","article-title":"A reality in our time\u2014certification of the global eradication of smallpox","volume":"142","author":"PF Wehrle","year":"1980","journal-title":"J Infect Dis"},{"issue":"27","key":"pone.0230711.ref002","first-page":"642","article-title":"Update: multistate outbreak of monkeypox\u2014Illinois, Indiana, Kansas, Missouri, Ohio, and Wisconsin, 2003","volume":"52","author":"Prevention CfDCa","year":"2003","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"pone.0230711.ref003","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.tim.2011.12.001","article-title":"Outbreaks of human monkeypox after cessation of smallpox vaccination","volume":"20","author":"MG Reynolds","year":"2012","journal-title":"Trends Microbiol"},{"issue":"10","key":"pone.0230711.ref004","doi-asserted-by":"crossref","first-page":"306","DOI":"10.15585\/mmwr.mm6710a5","article-title":"Emergence of Monkeypox\u2014West and Central Africa, 1970\u20132017","volume":"67","author":"KN Durski","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"pone.0230711.ref005","first-page":"1460","volume-title":"Smallpox and its eradication","author":"F Fenner","year":"1988"},{"issue":"22","key":"pone.0230711.ref006","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1001\/jama.281.22.2127","article-title":"Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense","volume":"281","author":"DA Henderson","year":"1999","journal-title":"JAMA"},{"issue":"2","key":"pone.0230711.ref007","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1086\/375825","article-title":"Smallpox vaccination: a review, part II. Adverse events","volume":"37","author":"VA Fulginiti","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"21","key":"pone.0230711.ref008","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1001\/jama.294.21.2734","article-title":"Adverse events associated with smallpox vaccination in the United States, January-October 2003","volume":"294","author":"CG Casey","year":"2005","journal-title":"JAMA"},{"issue":"6","key":"pone.0230711.ref009","doi-asserted-by":"crossref","first-page":"488","DOI":"10.7326\/0003-4819-138-6-200303180-00014","article-title":"Evaluation of 21st-century risks of smallpox vaccination and policy options","volume":"138","author":"JM Lane","year":"2003","journal-title":"Ann Intern Med"},{"issue":"2","key":"pone.0230711.ref010","first-page":"84","article-title":"Expected adverse events in a mass smallpox vaccination campaign","volume":"5","author":"AR Kemper","year":"2002","journal-title":"Eff Clin Pract"},{"issue":"3","key":"pone.0230711.ref011","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/phn.12291","article-title":"Estimating the Size of the U.S. Population at Risk of Severe Adverse Events from Replicating Smallpox Vaccine","volume":"34","author":"EP Carlin","year":"2017","journal-title":"Public Health Nurs"},{"issue":"Pt 2","key":"pone.0230711.ref012","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1099\/0022-1317-79-2-347","article-title":"Highly attenuated modified vaccinia virus Ankara replicates in baby hamster kidney cells, a potential host for virus propagation, but not in various human transformed and primary cells","volume":"79","author":"I Drexler","year":"1998","journal-title":"J Gen Virol"},{"issue":"1","key":"pone.0230711.ref013","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0042-6822(92)90752-B","article-title":"NYVAC: a highly attenuated strain of vaccinia virus","volume":"188","author":"J Tartaglia","year":"1992","journal-title":"Virology"},{"issue":"6040","key":"pone.0230711.ref014","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/317813a0","article-title":"Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype","volume":"317","author":"RM Buller","year":"1985","journal-title":"Nature"},{"issue":"6","key":"pone.0230711.ref015","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1128\/JVI.78.6.2770-2779.2004","article-title":"Induction of potent humoral and cell-mediated immune responses by attenuated vaccinia virus vectors with deleted serpin genes","volume":"78","author":"FA Legrand","year":"2004","journal-title":"J Virol"},{"issue":"1","key":"pone.0230711.ref016","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1128\/JVI.75.1.11-18.2001","article-title":"Vaccinia virus vectors with an inactivated gamma interferon receptor homolog gene (B8R) are attenuated In vivo without a concomitant reduction in immunogenicity","volume":"75","author":"PH Verardi","year":"2001","journal-title":"J Virol"},{"issue":"6145","key":"pone.0230711.ref017","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/330259a0","article-title":"Prevention of vaccinia virus infection in immunodeficient mice by vector-directed IL-2 expression","volume":"330","author":"C Flexner","year":"1987","journal-title":"Nature"},{"issue":"8","key":"pone.0230711.ref018","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1073\/pnas.89.8.3409","article-title":"Vaccinia virus recombinants expressing chimeric proteins of human immunodeficiency virus and gamma interferon are attenuated for nude mice","volume":"89","author":"LD Giavedoni","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"pone.0230711.ref019","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1073\/pnas.0409846102","article-title":"Vaccinia viruses with a serpin gene deletion and expressing IFN-gamma induce potent immune responses without detectable replication in vivo","volume":"102","author":"FA Legrand","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6139","key":"pone.0230711.ref020","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/329545a0","article-title":"Recovery of immunodeficient mice from a vaccinia virus\/IL-2 recombinant infection","volume":"329","author":"IA Ramshaw","year":"1987","journal-title":"Nature"},{"key":"pone.0230711.ref021","first-page":"235","volume-title":"Recombinant poxviruses","author":"R Buller","year":"1992"},{"issue":"6","key":"pone.0230711.ref022","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.imbio.2011.07.005","article-title":"Ipilimumab (Yervoy) and the TGN1412 catastrophe","volume":"217","author":"T Bakacs","year":"2012","journal-title":"Immunobiology"},{"issue":"1","key":"pone.0230711.ref023","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1128\/MMBR.05015-11","article-title":"Into the eye of the cytokine storm","volume":"76","author":"JR Tisoncik","year":"2012","journal-title":"Microbiol Mol Biol Rev"},{"issue":"2","key":"pone.0230711.ref024","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1128\/MMBR.65.2.232-260.2001","article-title":"Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance","volume":"65","author":"I Chopra","year":"2001","journal-title":"Microbiol Mol Biol Rev"},{"key":"pone.0230711.ref025","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1146\/annurev.mi.48.100194.002021","article-title":"Mechanisms underlying expression of Tn10 encoded tetracycline resistance","volume":"48","author":"W Hillen","year":"1994","journal-title":"Annu Rev Microbiol"},{"issue":"1","key":"pone.0230711.ref026","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1751-7915.2007.00001.x","article-title":"The application of Tet repressor in prokaryotic gene regulation and expression","volume":"1","author":"R Bertram","year":"2008","journal-title":"Microb Biotechnol"},{"issue":"4\u20135","key":"pone.0230711.ref027","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/BF00351693","article-title":"Construction of a tetracycline-inducible promoter in Schizosaccharomyces pombe","volume":"21","author":"K Faryar","year":"1992","journal-title":"Curr Genet"},{"issue":"5","key":"pone.0230711.ref028","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1073\/pnas.85.5.1394","article-title":"Tn10-encoded tet repressor can regulate an operator-containing plant promoter","volume":"85","author":"C Gatz","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"19","key":"pone.0230711.ref029","doi-asserted-by":"crossref","first-page":"10775","DOI":"10.1073\/pnas.121186498","article-title":"Tetracycline-inducible systems for Drosophila","volume":"98","author":"MJ Stebbins","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7\u20138","key":"pone.0230711.ref030","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.addr.2008.12.016","article-title":"In vivo gene regulation using tetracycline-regulatable systems","volume":"61","author":"K Stieger","year":"2009","journal-title":"Adv Drug Deliv Rev"},{"issue":"13","key":"pone.0230711.ref031","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1089\/hum.1998.9.13-1939","article-title":"Tetracycline repressor, tetR, rather than the tetR-mammalian cell transcription factor fusion derivatives, regulates inducible gene expression in mammalian cells","volume":"9","author":"F Yao","year":"1998","journal-title":"Hum Gene Ther"},{"issue":"2","key":"pone.0230711.ref032","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1084-9521(02)00018-6","article-title":"Tetracycline-controlled transcriptional regulation systems: advances and application in transgenic animal modeling","volume":"13","author":"Z Zhu","year":"2002","journal-title":"Semin Cell Dev Biol"},{"issue":"8","key":"pone.0230711.ref033","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1128\/JVI.74.8.3682-3695.2000","article-title":"Elucidating the essential role of the A14 phosphoprotein in vaccinia virus morphogenesis: construction and characterization of a tetracycline-inducible recombinant","volume":"74","author":"P Traktman","year":"2000","journal-title":"J Virol"},{"issue":"16","key":"pone.0230711.ref034","doi-asserted-by":"crossref","first-page":"8885","DOI":"10.1128\/JVI.78.16.8885-8901.2004","article-title":"Vaccinia virus morphogenesis: a13 phosphoprotein is required for assembly of mature virions","volume":"78","author":"B Unger","year":"2004","journal-title":"J Virol"},{"key":"pone.0230711.ref035","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.virusres.2013.12.033","article-title":"Antibiotic-dependent expression of early transcription factor subunits leads to stringent control of vaccinia virus replication","volume":"181","author":"CJ Hagen","year":"2014","journal-title":"Virus research"},{"issue":"13","key":"pone.0230711.ref036","doi-asserted-by":"crossref","first-page":"7590","DOI":"10.1128\/JVI.77.13.7590-7600.2003","article-title":"Poxvirus orthologous clusters: toward defining the minimum essential poxvirus genome","volume":"77","author":"C Upton","year":"2003","journal-title":"J Virol"},{"issue":"7","key":"pone.0230711.ref037","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1091\/mbc.12.7.2031","article-title":"Vaccinia virus DNA replication occurs in endoplasmic reticulum-enclosed cytoplasmic mini-nuclei","volume":"12","author":"N Tolonen","year":"2001","journal-title":"Mol Biol Cell"},{"issue":"19","key":"pone.0230711.ref038","doi-asserted-by":"crossref","first-page":"9773","DOI":"10.1128\/JVI.76.19.9773-9786.2002","article-title":"The Vaccinia virus E8R gene product: a viral membrane protein that is made early in infection and packaged into the virions\u2019 core","volume":"76","author":"L Doglio","year":"2002","journal-title":"J Virol"},{"issue":"2","key":"pone.0230711.ref039","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.virol.2007.05.002","article-title":"The vaccinia virus E8R gene product is required for formation of transcriptionally active virions","volume":"367","author":"SE Kato","year":"2007","journal-title":"Virology"},{"issue":"2","key":"pone.0230711.ref040","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0022-2836(73)90195-2","article-title":"Letter: Protein cleavage and poxvirus morphogenesis: tryptic peptide analysis of core precursors accumulated by blocking assembly with rifampicin","volume":"81","author":"B Moss","year":"1973","journal-title":"J Mol Biol"},{"issue":"2","key":"pone.0230711.ref041","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/0042-6822(72)90409-6","article-title":"Studies on the nature and location of the capsid polypeptides of vaccinia virions","volume":"50","author":"I Sarov","year":"1972","journal-title":"Virology"},{"issue":"2","key":"pone.0230711.ref042","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1006\/viro.1995.0061","article-title":"Organization of the vaccinia envelope and relationship to the structure of intracellular mature virions","volume":"214","author":"S Wilton","year":"1995","journal-title":"Virology"},{"key":"pone.0230711.ref043","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.virol.2014.11.020","article-title":"Fine structure of the vaccinia virion determined by controlled degradation and immunolocalization","volume":"475","author":"N Moussatche","year":"2015","journal-title":"Virology"},{"issue":"1","key":"pone.0230711.ref044","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.virol.2004.08.038","article-title":"Temperature-sensitive mutants in the vaccinia virus 4b virion structural protein assemble malformed, transcriptionally inactive intracellular mature virions","volume":"330","author":"SE Kato","year":"2004","journal-title":"Virology"},{"key":"pone.0230711.ref045","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.virol.2015.02.003","article-title":"Poxvirus membrane biogenesis","volume":"479\u2013480","author":"B Moss","year":"2015","journal-title":"Virology"},{"issue":"5","key":"pone.0230711.ref046","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1128\/JVI.80.5.2127-2140.2006","article-title":"Vaccinia virus proteome: identification of proteins in vaccinia virus intracellular mature virion particles","volume":"80","author":"CS Chung","year":"2006","journal-title":"J Virol"},{"issue":"1\u20132","key":"pone.0230711.ref047","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jviromet.2005.08.015","article-title":"Characterization of the major capsid proteins of myxoma virus particles using MALDI-TOF mass spectrometry","volume":"132","author":"A Zachertowska","year":"2006","journal-title":"J Virol Methods"},{"issue":"3","key":"pone.0230711.ref048","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1128\/JVI.02206-06","article-title":"Vaccinia virus A6L encodes a virion core protein required for formation of mature virion","volume":"81","author":"X Meng","year":"2007","journal-title":"J Virol"},{"issue":"10","key":"pone.0230711.ref049","doi-asserted-by":"crossref","first-page":"5603","DOI":"10.1128\/JVI.00330-12","article-title":"Vaccinia virus A6 is essential for virion membrane biogenesis and localization of virion membrane proteins to sites of virion assembly","volume":"86","author":"X Meng","year":"2012","journal-title":"J Virol"},{"issue":"10","key":"pone.0230711.ref050","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02405-16","article-title":"Vaccinia Virus A6 Is a Two-Domain Protein Requiring a Cognate N-Terminal Domain for Full Viral Membrane Assembly Activity","volume":"91","author":"X Meng","year":"2017","journal-title":"J Virol"},{"issue":"27","key":"pone.0230711.ref051","doi-asserted-by":"crossref","first-page":"7028","DOI":"10.1073\/pnas.1805855115","article-title":"Structure of a lipid-bound viral membrane assembly protein reveals a modality for enclosing the lipid bilayer","volume":"115","author":"PK Pathak","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"pone.0230711.ref052","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/0022-2836(89)90108-3","article-title":"Structure of vaccinia virus late promoters","volume":"210","author":"AJ Davison","year":"1989","journal-title":"J Mol Biol"},{"issue":"8","key":"pone.0230711.ref053","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1073\/pnas.86.8.2549","article-title":"Transfer of the inducible lac repressor\/operator system from Escherichia coli to a vaccinia virus expression vector","volume":"86","author":"TR Fuerst","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"pone.0230711.ref054","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.2144\/97236st07","article-title":"Compact, synthetic, vaccinia virus early\/late promoter for protein expression","volume":"23","author":"S Chakrabarti","year":"1997","journal-title":"Biotechniques"},{"key":"pone.0230711.ref055","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1743-422X-4-22","article-title":"Pathogeneses of respiratory infections with virulent and attenuated vaccinia viruses","volume":"4","author":"D Hayasaka","year":"2007","journal-title":"Virol J"},{"issue":"38","key":"pone.0230711.ref056","doi-asserted-by":"crossref","first-page":"15407","DOI":"10.1073\/pnas.1314483110","article-title":"Safety mechanism assisted by the repressor of tetracycline (SMART) vaccinia virus vectors for vaccines and therapeutics","volume":"110","author":"P Grigg","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"21","key":"pone.0230711.ref057","doi-asserted-by":"crossref","first-page":"11341","DOI":"10.1073\/pnas.93.21.11341","article-title":"Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety","volume":"93","author":"B Moss","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"pone.0230711.ref058","first-page":"201","article-title":"Applications of recombinant vaccinia virus for veterinary vaccines","volume":"82","author":"T Yilma","year":"1994","journal-title":"Dev Biol Stand"},{"issue":"1","key":"pone.0230711.ref059","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13567-017-0459-9","article-title":"Oral vaccination of wildlife using a vaccinia-rabies-glycoprotein recombinant virus vaccine (RABORAL V-RG((R))): a global review","volume":"48","author":"J Maki","year":"2017","journal-title":"Vet Res"},{"issue":"2","key":"pone.0230711.ref060","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1128\/JVI.76.2.484-491.2002","article-title":"Long-term sterilizing immunity to rinderpest in cattle vaccinated with a recombinant vaccinia virus expressing high levels of the fusion and hemagglutinin glycoproteins","volume":"76","author":"PH Verardi","year":"2002","journal-title":"J Virol"},{"issue":"7","key":"pone.0230711.ref061","doi-asserted-by":"crossref","first-page":"961","DOI":"10.4161\/hv.21080","article-title":"A vaccinia virus renaissance: new vaccine and immunotherapeutic uses after smallpox eradication","volume":"8","author":"PH Verardi","year":"2012","journal-title":"Hum Vaccin Immunother"},{"key":"pone.0230711.ref062","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3389\/fonc.2017.00096","article-title":"Genetically Engineered Vaccinia Viruses As Agents for Cancer Treatment, Imaging, and Transgene Delivery","volume":"7","author":"D Haddad","year":"2017","journal-title":"Front Oncol"},{"issue":"14","key":"pone.0230711.ref063","doi-asserted-by":"crossref","first-page":"7805","DOI":"10.1128\/JVI.03481-12","article-title":"Assessment of the protective effect of Imvamune and Acam2000 vaccines against aerosolized monkeypox virus in cynomolgus macaques","volume":"87","author":"GJ Hatch","year":"2013","journal-title":"J Virol"},{"key":"pone.0230711.ref064","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virol.2015.02.020","article-title":"Vaccinia virus protein A3 is required for the production of normal immature virions and for the encapsidation of the nucleocapsid protein L4","volume":"481","author":"DM Jesus","year":"2015","journal-title":"Virology"},{"issue":"20","key":"pone.0230711.ref065","doi-asserted-by":"crossref","first-page":"11276","DOI":"10.1128\/JVI.01502-12","article-title":"Vaccinia virus virion membrane biogenesis protein A11 associates with viral membranes in a manner that requires the expression of another membrane biogenesis protein, A6","volume":"86","author":"X Wu","year":"2012","journal-title":"J Virol"},{"issue":"6","key":"pone.0230711.ref066","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1128\/JVI.64.6.3108-3111.1990","article-title":"Transient dominant selection of recombinant vaccinia viruses","volume":"64","author":"FG Falkner","year":"1990","journal-title":"J Virol"},{"key":"pone.0230711.ref067","article-title":"EPPIC (Efficient Purification by Parental Inducer Constraint) Platform for Rapid Generation of Recombinant Vaccinia Viruses","author":"B Jasperse","year":"2020","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"4","key":"pone.0230711.ref068","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1086\/596553","article-title":"Severe postvaccinia encephalitis with acute disseminated encephalomyelitis: recovery with early intravenous immunoglobulin, high-dose steroids, and vaccinia immunoglobulin","volume":"48","author":"CN Van Dam","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"9","key":"pone.0230711.ref069","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1093\/infdis\/jis510","article-title":"Progressive vaccinia: case description and laboratory-guided therapy with vaccinia immune globulin, ST-246, and CMX001","volume":"206","author":"ER Lederman","year":"2012","journal-title":"J Infect Dis"},{"key":"pone.0230711.ref070","article-title":"Preemptive Tecovirimat Use in an Active Duty Member Presenting with Acute Myeloid Leukemia after Smallpox Vaccination","author":"DA Lindholm","year":"2019","journal-title":"Clin Infect Dis [Internet]"},{"issue":"8","key":"pone.0230711.ref071","first-page":"145","article-title":"Secondary and tertiary transmission of vaccinia virus after sexual contact with a smallpox vaccinee\u2014San Diego, California, 2012","volume":"62","author":"Prevention CfDCa","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"19","key":"pone.0230711.ref072","first-page":"478","article-title":"Household transmission of vaccinia virus from contact with a military smallpox vaccinee\u2014Illinois and Indiana, 2007","volume":"56","author":"Prevention CfDCa","year":"2007","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"pone.0230711.ref073","doi-asserted-by":"crossref","first-page":"730","DOI":"10.3201\/eid1704.101010","article-title":"Vaccinia virus infections in martial arts gym, Maryland, USA, 2008","volume":"17","author":"CM Hughes","year":"2011","journal-title":"Emerg Infect Dis"},{"issue":"8","key":"pone.0230711.ref074","first-page":"2","article-title":"Spread of vaccinia virus through shaving during military training, Joint Base San Antonio-Lackland, TX, June 2014","volume":"21","author":"BJ Webber","year":"2014","journal-title":"MSMR"},{"issue":"2","key":"pone.0230711.ref075","doi-asserted-by":"crossref","first-page":"276","DOI":"10.2144\/97222bm17","article-title":"gpt-gus fusion gene for selection and marker in recombinant poxviruses","volume":"22","author":"JX Cao","year":"1997","journal-title":"Biotechniques"},{"issue":"6","key":"pone.0230711.ref076","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1128\/JVI.62.6.1849-1854.1988","article-title":"Escherichia coli gpt gene provides dominant selection for vaccinia virus open reading frame expression vectors","volume":"62","author":"FG Falkner","year":"1988","journal-title":"J Virol"},{"key":"pone.0230711.ref077","article-title":"Generation of recombinant vaccinia viruses","author":"PL Earl","year":"2001","journal-title":"Curr Protoc Mol Biol"},{"issue":"5","key":"pone.0230711.ref078","first-page":"564","article-title":"A rapid method for screening vaccinia virus recombinants","volume":"10","author":"AC Lai","year":"1991","journal-title":"Biotechniques"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0230711","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,7]],"date-time":"2021-03-07T04:24:23Z","timestamp":1615091063000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0230711"}},"subtitle":[],"editor":[{"given":"Victoria Ann","family":"Olson","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,4,2]]},"references-count":78,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,4,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0230711","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,2]]}}}